Streptococcal Infections: Clinical Trials

83 trials for Streptococcal Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

65 completed, 6 recruiting, 6 unknown, 2 active not recruiting. 83 Phase 1, 19 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 183Completed 65, Recruiting 6, Unknown 6, Active not recruiting 2, Not yet recruiting 2, Terminated 1, Withdrawn 1
Phase 219Completed 16, Active not recruiting 1, Not yet recruiting 1, Recruiting 1

Follow Streptococcal Infections: new trials by email Literature Review of Streptococcal Infections trials Research Report on Streptococcal Infections

Trials (filtered) newest first · largest first

All 83 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-A1 in Healthy Young Adults
Placebo, VAX-A1 Low, VAX-A1 Mid - Group A Streptococcal Infection
Phase 1RecruitingVaxcyte, Inc.802026-06-012026-06-16
Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)
24-valent pneumococcal polysaccharide conjugate vaccine (CRM197/tetanus toxoid) (referred to as PCV24) (dose M), PCV24 vaccine (dose H), PCV24 vaccine (dose M) - Streptococcus Pneumoniae Infection
Phase 1 / Phase 2RecruitingCanSino Biologics Inc.8542026-05-242026-08-05
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
V118C (Stage 1), V118C (Stage 2), PCV20 (Stage 1) - Pneumococcal Infection
Phase 1RecruitingMerck Sharp & Dohme LLC2102026-01-132026-10-02
Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor
StrepIncor, Placebo - Rheumatic Heart Disease, Rheumatic Heart Disease in Children
Phase 1 / Phase 2Not yet recruitingUniversity of Sao Paulo General Hospital602025-10-012025-07-22
Serum Collection Study for Assay Development
Gamma-PN - Pneumococcal Disease, Invasive, Pneumococcal Disease
Phase 1RecruitingGPN Vaccines122025-10-012025-10-03
A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young Adults
Low dose Strep A Alum, Medium dose Strep A Alum, High dose Strep A Alum - Streptococcal Infections
Phase 1RecruitingGlaxoSmithKline1082025-07-292026-08-11
A Study to Learn About How Safe and Effective is 20vPnC and 13vPnC Vaccines in Chinese Adults
20vPnC, 13vPnC - Pneumococcal Disease
Phase 1CompletedPfizer4002025-07-062026-02-25
Clinical Trial of PCV24 in Adults Aged ≥18 Years
Sinovac Low-dosage PCV24, Sinovac Middle-dosage PCV24, Sinovac High-dosage PCV24 - Pneumococcal Infectious Disease
Phase 1 / Phase 2CompletedSinovac Life Sciences Co., Ltd.3852025-06-182026-04-21
A Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and Infant
20vPnC, 13vPnC - Pneumococcal Disease
Phase 1Active not recruitingPfizer2002025-06-152026-10-23
A Phase I Clinical Study to Evaluate the Safety of PCV26 in Individuals ≥60
26-valent Pneumococcal Conjugate Vaccine, 13-valent Pneumococcal Conjugate Vaccine - Pneumococcal Diseases
Phase 1Not yet recruitingBeijing Zhifei Lvzhu Biopharmaceutical Co., Ltd602025-05-272025-05-18
Clinical Trial of PCV24 in Infants Aged 2-23 Months
Sinovac PCV24, Prevnar® - Pneumococcal Infectious Disease
Phase 1RecruitingSinovac Life Sciences Co., Ltd.1802025-05-082026-01-28
Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age.
IVT GBS-06, Placebo - Group B Streptococcal Infections
Phase 1 / Phase 2Active not recruitingInventprise Inc.6002024-11-122025-11-18
Clinical Trial of PCV24 in Children Aged 2-17 Years
Sinovac PCV24 formulation 1, Sinovac PCV24 formulation 2, Prevenar13® - Pneumococcal Infectious Disease
Phase 1CompletedSinovac Life Sciences Co., Ltd.1192024-09-072026-01-28
Study of Gamma PN3 in the Elderly
Gamma PN3, Prevnar - Pneumonia, Pneumococcal
Phase 1CompletedGPN Vaccines1052024-08-262025-05-11
Clinical Trial of PCV24 in Adults
Sinovac PCV24 formulation 1, Sinovac PCV24 formulation 2, Pneumovax® - Pneumococcal Infectious Disease
Phase 1CompletedSinovac Life Sciences Co., Ltd.1702024-06-212025-04-16
Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years
PCV24 formulation 1, PCV24 formulation 2, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine - Pneumococcal Infectious Disease
Phase 1CompletedReinovax Biologics Co., LTD2302024-04-272026-08-17
A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine
Sinovac PCV13, PREVNAR 13 - Pneumococcal Infectious Disease
Phase 1CompletedSinovac Research and Development Co., Ltd.1402024-01-042026-01-28
A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults
Multivalent Pneumococcal Vaccine - Formulation 1, Multivalent Pneumococcal Vaccine - Formulation 2, 20-valent pneumococcal conjugate vaccine (20vPnC) - Pneumococcal Disease
Phase 1 / Phase 2CompletedPfizer17102023-12-202026-11-06
Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older
Reinovax PCV24 formulation 1, Reinovax PCV24 formulation 2, PPSV23 - Pneumococcal Infectious Disease
Phase 1CompletedReinovax Biologics Co., LTD2402023-11-192024-11-07
A Phase I Study of XJ103 in Chinese Healthy Subjects
XJ103 Injection, Placebo - Pneumococcal Disease
Phase 1UnknownStarmab biologics(Shanghai)Co,.ltd382023-09-122024-03-27

Showing 20 of 83. Sign in to see all of them.

Narrower conditions

Pneumococcal Infections (55)  ·  Pneumonia, Pneumococcal (10)  ·  Pneumonia (6)  ·  Staphylococcal Skin Infections (4)  ·  Pneumonia, Bacterial (3)  ·  Rheumatic Fever (3)  ·  Bacterial Infections (2)  ·  Cellulitis (2)  ·  HIV Infections (2)  ·  Rheumatic Heart Disease (2)  ·  AIDS-Related Complex (1)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Dental Caries (1)  ·  Gram-Positive Bacterial Infections (1)

Broader conditions

Bacterial Infections and Mycoses (83)  ·  Infections (83)  ·  Gram-Positive Bacterial Infections (82)  ·  Bacterial Infections (81)  ·  Lung Diseases (17)  ·  Respiratory Tract Diseases (17)  ·  Respiratory Tract Infections (17)  ·  Pneumonia (11)  ·  Pneumonia, Bacterial (9)  ·  Skin and Connective Tissue Diseases (8)  ·  Pneumococcal Infections (6)  ·  Connective Tissue Diseases (5)  ·  Skin Diseases (5)  ·  Skin Diseases, Bacterial (5)

Interventions

13-valent pneumococcal vaccine (15)  ·  Heptavalent Pneumococcal Conjugate Vaccine (9)  ·  23-valent pneumococcal capsular polysaccharide vaccine (8)  ·  Pneumococcal Vaccines (8)  ·  ceftobiprole (4)  ·  PHiD-CV vaccine (2)  ·  Sodium Chloride (2)  ·  Tetanus Toxoid (2)  ·  Vaccines, Combined (2)  ·  10-valent pneumococcal conjugate vaccine (1)  ·  CRM197 (non-toxic variant of diphtheria toxin) (1)  ·  Epinephrine (1)  ·  Mupirocin (1)  ·  Ointments (1)  ·  Pentavac (1)

Sponsors

Pfizer (8)  ·  GlaxoSmithKline (7)  ·  Merck Sharp & Dohme LLC (7)  ·  Sinovac Life Sciences Co., Ltd. (5)  ·  Basilea Pharmaceutica (4)  ·  GPN Vaccines (4)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (2)  ·  CanSino Biologics Inc. (2)  ·  Centers for Disease Control and Prevention (2)  ·  Minervax ApS (2)  ·  PATH (2)  ·  Reinovax Biologics Co., LTD (2)  ·  Sanofi (2)  ·  Sanofi Pasteur, a Sanofi Company (2)

Countries

United States (18)  ·  China (16)  ·  Australia (8)  ·  Belgium (5)  ·  Germany (3)  ·  South Korea (3)  ·  Switzerland (3)  ·  Bangladesh (2)  ·  Brazil (2)  ·  Canada (2)  ·  Japan (2)  ·  Kenya (2)  ·  South Africa (2)  ·  Sweden (2)  ·  United Kingdom (2)

Top investigators

Geoff Kitson (2)  ·  Kai Chu (2)  ·  Myoung-don Oh, M.D. (2)  ·  Andrew C Steer, MBBS,MPH,PhD (1)  ·  Anthony Scott, MD, PhD (1)  ·  Christopher Bailey, Bsc, PhD (1)  ·  Du Lin, Master (1)  ·  Ed Clarke, MD PhD (1)

Results publications

PMID 30689507, PMID 10212363, PMID 1053919, PMID 10709851, PMID 10717828, PMID 10895619, PMID 11139785, PMID 11199555, PMID 11321382, PMID 11409642, PMID 1157366, PMID 1170757, PMID 11875603, PMID 12436828, PMID 12685620, PMID 12723166, PMID 12767443, PMID 12873775, PMID 13263433, PMID 14446037, PMID 1452871, PMID 14894244, PMID 15190533, PMID 15851928, PMID 15882530, PMID 15917682, PMID 16022946, PMID 16175029, PMID 16175030, PMID 16648419, PMID 16695846, PMID 17391816, PMID 1812051, PMID 18799552, PMID 19522655, PMID 1984216, PMID 20435707, PMID 2213464, PMID 22353593, PMID 2263330, PMID 23123106, PMID 23131206, PMID 23153437, PMID 23300160, PMID 23535358, PMID 2365491, PMID 23967126, PMID 24176494, PMID 24599529, PMID 24607003

NIH funding

2009 (1), 2015 (1), 2017 (1), 2019 (1)